Ligand Pharmaceuticals (LGND) Inventory (2011 - 2026)
Ligand Pharmaceuticals (LGND) posted Inventory of $13.3 million for Q1 2026, up 45.36% sequentially from $9.1 million in Q4 2025, and down 9.22% YoY from $14.6 million in Q1 2025.
Ligand Pharmaceuticals (LGND) Inventory (2011 - 2026) Analysis & Trends
Ligand Pharmaceuticals has reported Inventory for 16 years, with the latest figure at $13.3 million in Q1 2026.
- Quarterly Inventory fell 9.22% year-over-year to $13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.3 million (down 9.22% YoY) and the FY2025 annual result came in at $9.1 million, down 35.34% from the prior year.
- Inventory improved to $13.3 million in Q1 2026 per LGND's latest filing, from $9.1 million in the prior quarter.
- Over five years, Inventory peaked at $26.9 million in Q2 2023 and troughed at $9.1 million in Q4 2025.
- A 5-year average of $18.3 million and a median of $16.7 million in 2024 frame the typical range for Inventory.
- The sharpest annual moves came in 2022 and 2023: Inventory plunged 51.35% in 2022, then jumped 80.3% in 2023.
- Over 5 years, Inventory stood at $13.3 million in 2022, then surged by 80.3% to $24.0 million in 2023, then slumped by 41.12% to $14.1 million in 2024, then sank by 35.34% to $9.1 million in 2025, then jumped by 45.36% to $13.3 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $13.3 million, $9.1 million, and $11.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn | 10.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.26 Mn |
| Mar 31, 2026 | 13.27 Mn |
| Dec 31, 2025 | 9.13 Mn |
| Sep 30, 2025 | 11.90 Mn |
| Jun 30, 2025 | 15.49 Mn |
| Mar 31, 2025 | 14.61 Mn |
| Dec 31, 2024 | 14.11 Mn |
| Sep 30, 2024 | 16.74 Mn |
| Jun 30, 2024 | 18.67 Mn |
| Mar 31, 2024 | 21.34 Mn |
| Dec 31, 2023 | 23.97 Mn |
| Sep 30, 2023 | 25.39 Mn |
| Jun 30, 2023 | 26.91 Mn |
| Mar 31, 2023 | 14.01 Mn |
| Dec 31, 2022 | 13.29 Mn |
| Sep 30, 2022 | 22.33 Mn |
| Jun 30, 2022 | 24.77 Mn |
| Mar 31, 2022 | 25.61 Mn |
| Dec 31, 2021 | 27.33 Mn |
| Sep 30, 2021 | 33.00 Mn |